SuppTable 2. Two-Hundred Probe Set Classifier Resulting from Prediction Analysis of Gene Expression Profiles of 53 Patients with Advanced Stage Papillary Serous Adenocarcinomas of the Ovary

SuppTable 3. Differential Gene Expression by MAGP2.  List of 389 probe sets that were identified as differentially expressed in OVCA429 cells under recMAGP2 treatment.

Table S1. Differentially expressed genes from microarray analysis of intestinal LECs (iLECs) versus dermal LECs (dLECs); comparison of expression profiles of 5 dLEC and 6 iLEC samples from different persons; Genes upregulated in iLECs

Table S2. Classification of genes differentially expressed in intestinal LECs (iLECs) versus dermal LECs (dLECs); Genes upregulated in iLECs

Table S2. Classification of genes differentially expressed in intestinal LECs (iLECs) versus dermal LECs (dLECs); Genes downregulated in iLECs

Table S1. Differentially expressed genes from microarray analysis of intestinal LECs (iLECs) versus dermal LECs (dLECs); comparison of expression profiles of 5 dLEC and 6 iLEC samples from different persons; Genes downregulated in iLECs

Tableÿ3ÿFunctional classification of the 23-genes corresponding to the predictive 25 probe sets

Table 3. Connectivity and gene significance of 20 selected hub genes

Additional File 1: List of 925 differentially expressed genes in response to mastic oil

TABLE 2 Informative 22 genes associated with peritoneal relapse

TABLE II. Microarray Analysis of Genes Involved in Angiogenesis (GO 0001525) showing the expression of 36 angiogenesis-related genes detected as 100% present either in cardiac derived adherent proliferating (CAP) cells  mesenchymal stem cells (MSC)  or fibroblasts

TABLE III. Microarray Analysis of Genes Involved in Heart Development (GO 0007507) and Muscle Development (GO 0007517) showing genes whose expression was detected as 100% present in CAP cells and/or MSC and/or normal donor human dermal fibroblasts

Table S2. List of human sequences with a >2-fold upregulation (top) and with a >2-fold downregulation (down) using the GeneChip Human Genome U133 Plus 2.0 Arrays (Affymetryx) after NSD1 knockdown by RNAi